University of Colorado Cancer Center
Playback speed
10 seconds
ASH 2023 Insights: "Results From a Ph1 Study of the All-Oral Regimen of CC-486 and Venetoclax For R/R AML"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Maria Amaya
By
Insights from 2023 ASH Annual Meeting
FEATURING
Maria Amaya
147 views
December 14, 2023
Login to view comments.
Click here to Login
Videos